Young Age, Liver Dysfunction, and Neurostimulant Use as Independent Risk Factors for Post-Traumatic Seizures: A Multiracial Single-Center Experience.

Nicodemus Edrick Oey, Pei Ting Tan, Shrikant Digambarrao Pande
Author Information
  1. Nicodemus Edrick Oey: Rehabilitation Medicine, SingHealth Residency, Singapore 169608, Singapore. ORCID
  2. Pei Ting Tan: Department of Rehabilitation Medicine, Changi General Hospital, Singapore 529889, Singapore.
  3. Shrikant Digambarrao Pande: Department of Rehabilitation Medicine, Changi General Hospital, Singapore 529889, Singapore.

Abstract

We aimed to determine the potentially modifiable risk factors that are predictive of post-traumatic brain injury seizures in relation to the severity of initial injury, neurosurgical interventions, neurostimulant use, and comorbidities. This retrospective study was conducted on traumatic brain injury (TBI) patients admitted to a single center from March 2008 to October 2017. We recruited 151 patients from a multiracial background with TBI, of which the data from 141 patients were analyzed, as 10 were excluded due to incomplete follow-up records or a past history of seizures. Of the remaining 141 patients, 33 (24.4%) patients developed seizures during long-term follow up post-TBI. Young age, presence of cerebral contusion, Indian race, low Glasgow Coma Scale (GCS) scores on admission, and use of neurostimulant medications were associated with increased risk of seizures. In conclusion, due to increased risk of seizures, younger TBI patients, as well as patients with low GCS on admission, cerebral contusions on brain imaging, and those who received neurostimulants or neurosurgical interventions should be monitored for post-TBI seizures. While it is possible that these findings may be explained by the differing mechanisms of injury in younger vs. older patients, the finding that patients on neurostimulants had an increased risk of seizures will need to be investigated in future studies.

Keywords

References

  1. Epilepsia Open. 2018 Jul 31;3(3):392-398 [PMID: 30187010]
  2. N Engl J Med. 1998 Jan 1;338(1):20-4 [PMID: 9414327]
  3. J Neurotrauma. 2011 May;28(5):755-62 [PMID: 21381863]
  4. J Neurol. 2009 May;256(5):796-802 [PMID: 19252806]
  5. Crit Care Med. 2007 Dec;35(12):2830-6 [PMID: 18074483]
  6. Neurology. 1980 Jul;30(7 Pt 1):683-9 [PMID: 7190235]
  7. Exp Neurol. 2017 Apr;290:85-94 [PMID: 28081963]
  8. Front Neurol. 2016 Mar 22;7:32 [PMID: 27047441]
  9. Neurosurg Focus. 2008 Oct;25(4):E3 [PMID: 18828701]
  10. Exp Neurol. 2016 Jan;275 Pt 3:316-327 [PMID: 26342753]
  11. J Neuroinflammation. 2020 Jun 17;17(1):193 [PMID: 32552898]
  12. J Neuroimmunol. 2015 Dec 15;289:143-51 [PMID: 26616884]
  13. Ann Pharmacother. 2021 Oct;55(10):1254-1266 [PMID: 33435717]
  14. Seizure. 2000 Oct;9(7):453-7 [PMID: 11034867]
  15. Neurology. 2010 Aug 31;75(9):792-8 [PMID: 20805525]
  16. J Clin Neurophysiol. 2005 Apr;22(2):99-106 [PMID: 15805809]
  17. Epilepsia. 2003;44(s10):21-6 [PMID: 14511391]
  18. N Engl J Med. 1990 Aug 23;323(8):497-502 [PMID: 2115976]
  19. Brain Behav Immun. 2017 Jul;63:197-209 [PMID: 27818218]
  20. Glia. 2018 Dec;66(12):2719-2736 [PMID: 30378170]
  21. Rev Neurol. 2002 Aug 16-31;35(4):362-6 [PMID: 12235569]
  22. J Cereb Blood Flow Metab. 2011 Feb;31(2):658-70 [PMID: 20717122]
  23. J Neurosci. 2017 Aug 16;37(33):7864-7877 [PMID: 28724747]
  24. Epilepsia. 2007 Sep;48(9):1785-1800 [PMID: 17521344]
  25. Chin J Traumatol. 2017 Apr;20(2):84-86 [PMID: 28325648]
  26. J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):441-5 [PMID: 23117492]
  27. Am J Health Syst Pharm. 2013 Dec 1;70(23):2064, 2067 [PMID: 24249751]
  28. Br J Pharmacol. 2016 Feb;173(4):692-702 [PMID: 25752446]
  29. Brain Behav Immun. 2017 Oct;65:90-94 [PMID: 28232173]
  30. Arch Neurol. 2000 Nov;57(11):1611-6 [PMID: 11074793]
  31. Brain Behav Immun. 2015 Mar;45:253-62 [PMID: 25555531]
  32. Neurobiol Dis. 2019 Mar;123:115-121 [PMID: 29859872]
  33. Epilepsia. 1999 May;40(5):584-9 [PMID: 10386527]
  34. Epilepsia. 2018 Jan;59(1):37-66 [PMID: 29247482]
  35. J Neurosurg. 1999 Nov;91(5):750-60 [PMID: 10541231]
  36. J Neuroinflammation. 2017 Jan 13;14(1):10 [PMID: 28086980]
  37. J Neuroinflammation. 2008 Jun 30;5:28 [PMID: 18590543]

MeSH Term

Humans
Brain Injuries
Retrospective Studies
Seizures
Risk Factors
Brain Injuries, Traumatic
Liver Diseases

Word Cloud

Created with Highcharts 10.0.0patientsseizuresinjuryriskbrainneurostimulantTBIincreasedneurosurgicalinterventionsusetraumatic141duepost-TBIYoungcerebrallowGCSadmissionyoungerneurostimulantsaimeddeterminepotentiallymodifiablefactorspredictivepost-traumaticrelationseverityinitialcomorbiditiesretrospectivestudyconductedadmittedsinglecenterMarch2008October2017recruited151multiracialbackgrounddataanalyzed10excludedincompletefollow-uprecordspasthistoryremaining33244%developedlong-termfollowagepresencecontusionIndianraceGlasgowComaScalescoresmedicationsassociatedconclusionwellcontusionsimagingreceivedmonitoredpossiblefindingsmayexplaineddifferingmechanismsvsolderfindingwillneedinvestigatedfuturestudiesAgeLiverDysfunctionNeurostimulantUseIndependentRiskFactorsPost-TraumaticSeizures:MultiracialSingle-CenterExperienceneuromodulationneurosurgeryrehabilitation

Similar Articles

Cited By

No available data.